Company
Hetero
India - Hyderabad
MILNACIPRAN HYDROCHLORIDE (milnacipran hydrochloride) by Hetero is unknown. Approved for fibromyalgia (). First approved in 2024.
Drug data last refreshed 19h ago
unknown. Preclinical studies have shown that milnacipran is a potent inhibitor of neuronal norepinephrine and serotonin reuptake; milnacipran inhibits norepinephrine uptake with approximately 3-fold higher potency in vitro than serotonin without directly affecting the uptake of dopamine or other…
Worked on MILNACIPRAN HYDROCHLORIDE at Hetero? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Hetero is hiring 1 role related to this product